Pulmonary Function and Neuromuscular Disease

This study aims to describe the evolution of pulmonary function in 3 neuromuscular diseases : Duchenne muscular dystrophy, Werdnig-Hoffinann disease, congenital myopathy, monitored in Besançon university hospital.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Neuromuscular Diseases Nervous System Diseases

Age range

6 year–17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Besançon

Besançon, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Neuromuscular disease
Followed-up in Besançon University Hospital
With at least 2 Pulmonary Function Tests previously performed

Exclusion criteria

Mental deficiency
Facial expressions disorders

Treatment and study plan

Primary outcomes

FVC (Forced Vital Capacity)

Time frame: Year 12

Percentage of decrease of FVC sitting or lying down

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Besancon

Other

Registry information

Acronym: PREMDEN

Important dates

Study start: 2018
Primary completion: 2018
Study completion: 2018
First posted: Feb 26, 2018
Registry last updated: Aug 17, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed